The stock was last quoted at $56.91, down 18%, on volume of more than 400,000, according to Nasdaq.com. "Our first quarter performance was mixed versus our expectations," stated Angel Martinez, President, Chief Executive Officer and Chair of the Board of Directors. "Sales growth was driven by the addition of the Sanuk brand combined with increased demand for the UGG brand spring line, partially offset by softness in boots due to the unusually warm weather. The difference in the channel mix versus projections, along with some higher closeouts for the Teva brand and non-Classic UGG brand styles, put some additional pressure on overall gross margins on top of the higher product costs we had forecasted." Deckers attributed its lower full-year outlook to the higher costs of goods sold and increasing levels of closeout sales. Check out TheStreet's quote page for Deckers Outdoor for year-to-date share performance, analyst ratings, earnings estimates and much more.
Allscripts Health SolutionsShares of Allscripts Health Solutions ( MDRX) plunged late Thursday after the company's first-quarter results fell far short of Wall Street expectations because of weak sales, elevated software development expenses and an unfavorable sales mix. The company reported non-GAAP earnings of 12 cents a share on revenue of $365.5 million for the March quarter. The average estimate of analysts polled by Thomson Reuters was for earnings of 24 cents a share on revenue of $387.7 million. Allscripts also lowered its outlook, announced that Chief Financial Officer Bill Davis is leaving the company, and disclosed a shake-up of its board with Phil Pead being terminated as chairman and three other directors resigning. The stock dropped 46% to $8.70 on after-hours volume of 5.3 million.